翻訳と辞書 |
Veltuzumab
Veltuzumab is a monoclonal antibody (targeted at CD20) which is being investigated for the treatment of non-Hodgkin's lymphoma.〔(Statement On A Nonproprietary Name Adopted By The USAN Council - Veltuzumab ), ''American Medical Association''.〕 , it is undergoing Phase I/II clinical trials. When used with milatuzumab it showed activity.〔(The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma. )〕 This drug was developed by Immunomedics, Inc. and was originally known as IMMU-106.〔(Handbook of Therapeutic Antibodies. p791 )〕 In August 2015 the US FDA granted it orphan drug status for immune thrombocytopenia (ITP).〔(FDA grants orphan drug designation to veltuzumab for ITP )〕 A phase II trial is planned to run for 5 years.〔 ==See also==
*CD20 antagonist
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Veltuzumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|